Roberto Valvo

MD, Cardiology Fellow, Resident in Cardiovascular Diseases - A.O.U. Policlinico “G. Rodolico-San Marco”, Catania, Italy

[EuroIntervention @EuroInterventio]

In patients with severe AS and stable CAD scheduled for TAVI, performance of PCI after TAVI seems to be associated with improved 2-year clinical outcomes compared with other revascularisation timing strategies. https://t.co/H1uePWatGf

[Davide Capodanno @DFCapodanno]

In the international REVASC-TAVI registry, among patients with severe aortic stenosis and stable CAD scheduled for TAVI, PCI "after" the aortic intervention was associated with better 2-year outcomes compared with other revascularisation timing strategies. https://t.co/e7YqKJweNJ

[Tobias Rheude @TRheude]

Different PCI timing strategies in TAVI patients are discussed daily in our clinical practice. ➡️ Check out our latest collaborative work from the REVASC-TAVI registry now available in @EuroInterventio Great team work of 30 international TAVI centers!

[Marco Barbanti @barbanti_marco]

New evidence on coronary revascularization in TAVI setting from the REVASC-TAVI Registry: should we pospone PCI after TAVI? @EuroInterventio https://t.co/TksgwJEvDT

[Andrea Picci, MD @andreapicci990]

Talking about #reaccess and #TAVR commissural alignment with @barbanti_marco at #JIMGISE2023

@sicigise

[Marco Barbanti @barbanti_marco]

Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation https://t.co/z3LUllWFT3

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention, by Valvo et al
https://t.co/K9xqtlyJnh
#MinervaCardiologyAngiology
@RobertoValvo

[EuroIntervention @EuroInterventio]

This review aims to summarise literature data about coronary access after #TAVI and examine the underlying conditions that make coronary re-engagement more challenging or even impossible.#EIJBestOf https://t.co/gEeImu8zjq @RobertoValvo @barbanti_marco @tambucor

[Roberto Valvo @RobertoValvo]

Minerva Cardiology and Angiology 2022 Oct 28 - Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention @EdMinMedica https://t.co/DWCpTV3sgC

[EuroIntervention @EuroInterventio]

In this study of patients undergoing transfemoral #TAVI, the upfront use of a collagen-based plug system on top of a suture-based closure device reduced the risk of major vascular complications and major or life-threatening bleeding. #EIJBestOf https://t.co/QD055J1uoN

[Philippe Pibarot @PPibarot]

In OPERA-TAVI registry, SE and BE THVs had comparable success rates, but BE had a higher rate of early safety due lower stroke rates. BE also had lower rate of PVL but higher residual gradients vs SE. We need RCTs: BEST & SMART are ongoing.
@jaccjournals https://t.co/HmIVf27vFx

[Marco Barbanti @barbanti_marco]

Just out @JACCJournals #JACCIntv, the OPERA-TAVI Registry comparing latest gen #EvolutPRO vs #SapienUltra THVs. Thanks @costagiuliano90 for leading the project, all coauthors and @GilbertTangMD for his great editorial. Results will presented by @ClaudiaRed92 at @TCTConference

[Lorenzo Scalia @drlorenzoscalia]

In this review we aimed to summarise current evidence of antithrombotic management for acute stroke and transient ischemic attack.
@dario_calderone @DFCapodanno @tandfonline
#Antiplatelet #Antithrombotic #Stroke #TIA #CardioTwitter #ExpertReview

https://t.co/TT1IRUqmoj

[Dr. Gilbert Tang @GilbertTangMD]

Congrats @MAvvedimento and DrSyedZaid @HMethodistCV on their 1st @JACCJournals #JACCINTV SOTA #TAVR review! @SachinGoelMD

[Roberto Valvo @RobertoValvo]

Center Valve Preference and Outcomes of Transcatheter Aortic Valve Rep... https://t.co/GhUg50KNXo

[Roberto Valvo @RobertoValvo]

Sinus of Valsalva Sequestration Following Transcatheter-Based Manageme... https://t.co/Io1W8KPOvr

[REC Publications @RevEspCardiol]

La importancia de predecir la orientación de las neocomisuras al preparar un TAVI #REC #Editorial #Cardiotwitter @barbanti_marco @RobertoValvo
https://t.co/Zn1nR5rK8l

[Marco Barbanti @barbanti_marco]

When technology in #TAVR makes the difference! After adjusting for multiple baseline characteristics, this was the clinical impact of new gen TAVR devices in Italy.

[Giuliano Costa @costagiuliano90]

This real-world analysis from #OBSERVANT studies has proven that advancements in the #TAVI field over the past decade have resulted in significant benefits for patients, regardless of their risk profile

[Roberto Valvo @RobertoValvo]

Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement
https://t.co/ScIgivjscg
@costagiuliano90 @tambucor @barbanti_marco